0001104659-21-002487.txt : 20210108 0001104659-21-002487.hdr.sgml : 20210108 20210108163042 ACCESSION NUMBER: 0001104659-21-002487 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210106 FILED AS OF DATE: 20210108 DATE AS OF CHANGE: 20210108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAY WILLIAM GARRETT CENTRAL INDEX KEY: 0001692961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38128 FILM NUMBER: 21517795 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc. CENTRAL INDEX KEY: 0001651407 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472568632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 212-554-4366 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 4 1 tm212167-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-01-06 0 0001651407 Checkpoint Therapeutics, Inc. CKPT 0001692961 GRAY WILLIAM GARRETT 2 GANSEVOORT ST 9TH FLOOR NEW YORK NY 10014 0 1 0 0 Chief Financial Officer COMMON STOCK (RESTRICTED) 2021-01-06 4 A 0 151000 0.00 A 508490 D The shares of restricted stock vest as follows: one-fourth on January 6, 2022, one-fourth on January 6, 2023, one-fourth on January 6, 2024 and one-fourth on January 6, 2025. Includes shares of restricted Common Stock, which vest over various time periods. /s/ Garrett Gray 2021-01-08